Amir Sharabi

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Anti-Inflammatory and Survival Benefits of Dipeptidyl Peptidase 4 Inhibitors Among Patients with Gout, T2DM Patients and Chronic Kidney Disease.

Anti-Inflammatory and Survival Benefits of Dipeptidyl Peptidase 4 Inhibitors Among Patients with Gout, T2DM Patients and Chronic Kidney Disease.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: April 29, 2025

Occult myocardial injury is prevalent amongst elderly patients in the hospital-at-home setting. A retrospective analysis of 213 patients.

Occult myocardial injury is prevalent amongst elderly patients in the hospital-at-home setting. A retrospective analysis of 213 patients.

Journal: International journal of cardiology. Cardiovascular risk and prevention

Published: August 14, 2023

Adult-onset Still's disease following mRNA COVID-19 vaccination.

Adult-onset Still's disease following mRNA COVID-19 vaccination.

Journal: Clinical immunology (Orlando, Fla.)

Published: November 02, 2021

Updates on Clinical Trials in Systemic Lupus Erythematosus.

Updates on Clinical Trials in Systemic Lupus Erythematosus.

Journal: Current rheumatology reports

Published: April 21, 2021

PPP2R2D suppresses IL-2 production and Treg function.

PPP2R2D suppresses IL-2 production and Treg function.

Journal: JCI insight

Published: March 17, 2020

T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy.

T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy.

Journal: Nature reviews. Rheumatology

Published: December 05, 2019

Serine/threonine phosphatase PP2A is essential for optimal B cell function.

Serine/threonine phosphatase PP2A is essential for optimal B cell function.

Journal: JCI insight

Published: May 29, 2019

Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.

Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.

Journal: Nature communications

Published: April 05, 2019

PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.

PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.

Journal: JCI insight

Published: March 27, 2019

Regulatory T cells in the treatment of disease.

Regulatory T cells in the treatment of disease.

Journal: Nature reviews. Drug discovery

Published: October 13, 2018

Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1.

Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 10, 2018

The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.

The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.

Journal: Clinical immunology (Orlando, Fla.)

Published: April 29, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026